Expanding Polycyclic Tetramate Macrolactam (PoTeM) Core Structure Diversity by Chemo-Enzymatic Synthesis and Bioengineering

Tobias Gulder,Sebastian Schuler,Manuel Einsiedler,Julia Evers,Mert Malay,Valdet Uka,Sabine Schneider

DOI: https://doi.org/10.26434/chemrxiv-2024-lk0pg

2024-10-17

Abstract:Polycyclic tetramate macrolactams (PoTeMs) represent a growing class of bioactive natural products that are derived from a common tetramate polyene precursor, lysobacterene A, produced by an unusual bacterial iterative polyketide synthase (PKS) / non-ribosomal peptide synthetase (NRPS). The structural and functional diversity of PoTeMs is biosynthetically elaborated from lysobacterene A by pathway-specific cyclizing and modifying enzymes. This results in diverse core structure decoration and cyclization patterns. However, approaches to directly edit the PoTeM carbon skeleton are currently not existing. We thus set out to modify the PoTeM core structure by exchanging the natural L-ornithine-derived building block by L-lysine, hence extending macrocycle size by an additional CH2 group. We developed streamlined synthetic access to lysobacterene A and the corresponding extended analog and achieved cyclization of both precursors by the cognate PoTeM cyclases IkaBC in vitro. This chemo-enzymatic approach corroborated the catalytic competence of IkaBC to produce a larger macrolactam yielding homo-ikarugamycin. We thus engineered the adenylation domain active site of IkaA to directly accept L-lysine, which upon co-expression with IkaBC delivered a recombinant bacterial homo-ikarugamycin producer. Our work establishes an entirely new PoTeM structural framework and sets the stage for the biotechnological diversification of the PoTeM natural product class in general.

Chemistry

What problem does this paper attempt to address?

The problem this paper attempts to address is how to expand the diversity of the core structure of polycyclic tetramate macrolactams (PoTeMs). Specifically, the authors aim to introduce an additional CH2 group into the core skeleton of PoTeMs by replacing the naturally occurring L-ornithine-derived building blocks with L-lysine through chemo-enzymatic synthesis and bioengineering methods, thereby generating novel PoTeM analogs with larger ring structures—homo-ikarugamycin. This study not only validates the substrate promiscuity of the related enzymes but also lays the foundation for further diversification of PoTeM natural products through biotechnological means in the future.